Orphan Drug Designation

We provide full support to obtain orphan drug designation in Japan
Lead Consultations with MHLW and interaction until designation is received
Robust strategy for ODD including risks and mitigation measures
We also support process of obtaining funding from the Japanese government

We are your gateway for success in Japan